Widgets for Webmasters
Alnylam Obtains Continued Funding From NIAID for Anti-Viral Program
redorbit.com 4 hrs ago 5 relatedAlnylam Pharmaceuticals has announced that the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, has committed to $7.5 million of continued funding related to the 2006...

